Town & Country Bank & Trust CO dba First Bankers Trust CO Sells 3,693 Shares of Eli Lilly And Co (NYSE:LLY)
Town & Country Bank & Trust CO dba First Bankers Trust CO lowered its position in Eli Lilly And Co (NYSE:LLY) by 9.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 34,184 shares of the company’s stock after selling 3,693 shares during the period. Eli Lilly And Co makes up approximately 1.7% of Town & Country Bank & Trust CO dba First Bankers Trust CO’s investment portfolio, making the stock its 19th biggest holding. Town & Country Bank & Trust CO dba First Bankers Trust CO’s holdings in Eli Lilly And Co were worth $3,787,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in LLY. Comerica Securities Inc. grew its holdings in Eli Lilly And Co by 80.6% in the fourth quarter. Comerica Securities Inc. now owns 4,154 shares of the company’s stock worth $481,000 after purchasing an additional 1,854 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Eli Lilly And Co by 0.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,070,587 shares of the company’s stock worth $239,597,000 after purchasing an additional 18,958 shares during the last quarter. Geode Capital Management LLC grew its holdings in Eli Lilly And Co by 6.8% in the fourth quarter. Geode Capital Management LLC now owns 13,108,002 shares of the company’s stock worth $1,514,582,000 after purchasing an additional 830,689 shares during the last quarter. British Airways Pensions Investment Management Ltd purchased a new position in Eli Lilly And Co in the fourth quarter worth $7,164,000. Finally, Hancock Whitney Corp grew its holdings in Eli Lilly And Co by 17.1% in the fourth quarter. Hancock Whitney Corp now owns 30,522 shares of the company’s stock worth $3,532,000 after purchasing an additional 4,450 shares during the last quarter. 79.38% of the stock is owned by institutional investors and hedge funds.
In other Eli Lilly And Co news, CFO Joshua L. Smiley acquired 426 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The stock was bought at an average price of $118.03 per share, with a total value of $50,280.78. Following the purchase, the chief financial officer now owns 30,410 shares in the company, valued at $3,589,292.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Michael J. Harrington sold 16,000 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $116.72, for a total transaction of $1,867,520.00. Following the sale, the vice president now directly owns 110,300 shares of the company’s stock, valued at approximately $12,874,216. The disclosure for this sale can be found here. 0.11% of the stock is owned by insiders.
NYSE LLY opened at $108.27 on Friday. The firm has a market capitalization of $105.11 billion, a P/E ratio of 19.51, a PEG ratio of 1.91 and a beta of 0.20. The firm’s fifty day simple moving average is $111.93. Eli Lilly And Co has a 1 year low of $95.02 and a 1 year high of $132.13. The company has a quick ratio of 0.85, a current ratio of 1.12 and a debt-to-equity ratio of 5.50.
Eli Lilly And Co (NYSE:LLY) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $1.33 earnings per share for the quarter, topping analysts’ consensus estimates of $1.32 by $0.01. The business had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $5.12 billion. Eli Lilly And Co had a net margin of 26.13% and a return on equity of 56.62%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, equities analysts predict that Eli Lilly And Co will post 5.66 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 10th. Shareholders of record on Thursday, August 15th will be given a $0.645 dividend. The ex-dividend date is Wednesday, August 14th. This represents a $2.58 dividend on an annualized basis and a dividend yield of 2.38%. Eli Lilly And Co’s dividend payout ratio (DPR) is currently 46.49%.
About Eli Lilly And Co
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.
Read More: Conference Calls and Individual Investors
Receive News & Ratings for Eli Lilly And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly And Co and related companies with MarketBeat.com's FREE daily email newsletter.